UnitedHealth Group Incorporated

2026 performance & guidance; confidence in 13%–16% growth target - Q3 2026: revenue $113B and adjusted EPS $4.69 (vs $2.92 a year ago). Consolidated medical care ratio 88.4% (vs 89.9%). - Updated 2026 adjusted EPS guidance: at least $20.50, described as reflecting strong YTD performance through Q3 offset by expected investments in the final months. - Management reiterated it’s positioned to finish 2026 strongly and sustain 13%–16% long-term growth; for 2027, CEO suggested street consensus may understate opportunity, with the lower end of the long-term range viewed as a reasonable starting point.

Key strategic shift: modernization + “agentic”/AI + integrated value-based care - Enterprise modernization aims to make policies/processes/tools simpler and faster, and to build agentic infrastructure that improves access while lowering costs. - AI productivity examples cited: - AI chart summarization expanded to >40% of employed clinicians, cutting chart review time by 33%. - AI information gathering/research shortened appeal cycle times by 26%. - AI-powered plan recommendation for Medicare AEP 2027 to simplify member selection using care history + local plan options. - Investors should note: company is framing AI not as isolated pilots but as scaling operationally across clinicians/admin workflows.

Medicare Advantage: AEP coming; margin outlook and Stars focus - Medicare Advantage remains central; they emphasized strong value proposition (members save >$4,000 annually on average vs original Medicare). - 2027 product posture: prioritize high-value HMO, chronic/special needs (C-SNP), and dual/special needs (D-SNP); claim >94% of Medicare-eligible individuals have access to UHG MA plans; ~90% have access to a $0 premium option. - Stars outlook: initial payment year 2028 Stars reflect investment/operational execution; expectation to approach ~75% of members in 4+ Star plans vs industry ~70%. - 2026 MA margin (pacing) expectation: CFO/exec stated they now expect near the top end of a 2%–4% range (described as driven by recovery actions, medical trend/cost management, and durable product offerings plus quality/AI/provider work).